medigraphic.com
SPANISH

Revista Cubana de Medicina General Integral

ISSN 1561-3038 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 4

<< Back Next >>

Rev Cubana Med Gen Integr 2020; 36 (4)

Noonan Syndrome and severe aortic regurgitation in an adult patient

Moreno-Loaiza O, Flores-Lovon K, Montes-Madariaga ES
Full text How to cite this article

Language: Spanish
References: 13
Page: 1-8
PDF size: 391.69 Kb.


Key words:

Noonan syndrome, endocarditis, aortic valve regurgitation.

ABSTRACT

Introduction: Noonan syndrome is a congenital disease with an incidence of 1: 1000-2500 live newborns. Due to its clinical variability, it is underdiagnosed in our setting, which does not allow adequate control and follow-up to detect complications resulting from congenital cardiovascular defects. In Peru, there are no case reports on Noonan syndrome and its complications.
Objective: To discuss the importance of clinical examination for adequate diagnosis of Noonan syndrome, based on the characteristics of the disease in an adult.
Clinical case: We present the case of a 33-year-old male patient with Noonan syndrome, infective endocarditis, and severe aortic regurgitation.
Conclusions: The importance of physical examination and the use of diagnostic criteria to diagnose Noonan syndrome are highlighted.


REFERENCES

  1. Pierpont ME, Digilio MC. Cardiovascular disease in Noonan syndrome. Curr Opin Pediatr. 2018 [acceso: 07/04/2020];30(5):601-8. Disponible en: https://journals.lww.com/co-pediatrics/Abstract/2018/10000/Cardiovascular_disease_in_Noonan_syndrome.3.aspx

  2. Athota J, Bhat M, Nampoothiri S, Gowrishankar K, Narayanachar S, Puttamallesh V, et al. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations. BMC Medical Genetics. 2020 [acceso: 07/04/2020];21(1):50. Disponible en: https://bmcmedgenet.biomedcentral.com/articles/10.1186/s12881-020-0986-5

  3. Tafazoli A, Eshraghi P, Koleti ZK, Abbaszadegan M. Noonan syndrome - A new survey. Arch Med Sci. 2017 [acceso: 07/04/2020];13(1):215-22. Disponible en: https://www.termedia.pl/Noonan-syndrome-a-new-survey,19,28939,0,1.html

  4. Kruszka P, Porras AR, Addissie YA, Yonit A, Addissie Angélica Moresco, Sofía Medrano, et al. Noonan syndrome in diverse populations. Am J Med Genet A. 2017 [acceso: 07/04/2020];173(9):2323-34. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1002/ajmg.a.38362

  5. Yart A, Edouard T. Noonan syndrome: an update on growth and development. Curr Opin Endocrinol Diabetes Obes. 2018 [acceso: 07/04/2020];25(1):67-73. Disponible en: https://www.termedia.pl/Noonan-syndrome-a-new-survey,19,28939,0,1.html

  6. Linglart L, Gelb B. Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2020 [acceso: 07/04/2020];184(1):73-80. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1002/ajmg.c.31765

  7. Guía para la categorización de establecimientos de salud del sector, Resolución Ministerial 546-2011/MINSA. Lima: El Peruano; 2011 [acceso: 07/04/2020]. Disponible en: Disponible en: http://www.digemid.minsa.gob.pe/UpLoad/UpLoaded/PDF/AtencionFarmaceutica/Categorizacion-UPSS_Farmacia.pdf

  8. Resolución Ministerial N° 151-2014-MINSA Listado de Enfermedades Raras o Huérfanas. Gob.pe. 2020 [acceso: 07/04/2020]. Disponible en: https://www.gob.pe/institucion/minsa/normas-legales/197675-151-2014-

  9. Guio H, Poterico JA, Levano KS, et al. Genetics and genomics in Peru: Clinical and research perspective. Mol Genet Genomic Med. 2018 acceso: 07/04/2020;6(6):873-86. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/mgg3.533

  10. Azuola-Herra S, Vargas-Mojica S, París-Azuola R. Síndrome de NOONAN. Revisión bibliográfica y reporte de caso clínico. Revista Científica Odontológica. 2020 [acceso: 07/04/2020];11(2). Disponible en: https://revistaodontologica.colegiodentistas.org/index.php/revista/article/view/315

  11. Tajan M, Paccoud R, Branka S, Edouard T, Yart A. The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway. Endocr Rev. 2018 acceso: 07/04/2020;39(5):676-700. Disponible en: https://academic.oup.com/edrv/article/39/5/676/5038373

  12. Carcavilla Urquí A, Ezquieta Zubicaray B. Guía para pacientes con síndrome de Noonan y otras RASopatías y sus familiares. Cantabría: Asociación Síndrome Noonan de Cantabria; 2020 [acceso: 07/04/2020]. Disponible en: Disponible en: https://www.orpha.net/data/patho/Pub/Ext/es/GUIA_S_N_RASOPATIAS_Neurofibromatosis.pdf

  13. Abarca Barriga HH, Chávez Pastor M, Trubnykova M, La Serna-Infantes JE, Poterico JA. Factores de riesgo en las enfermedades genéticas. Acta Med Peru. 2018 acceso: 07/04/2020;35(1):44. Disponible en: http://amp.cmp.org.pe/index.php/AMP/article/view/368/262




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Med Gen Integr. 2020;36